These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 27001396

  • 1. Simple Estimation of the Endolymphatic Volume Ratio after Intravenous Administration of a Single-dose of Gadolinium Contrast.
    Naganawa S, Kanou M, Ohashi T, Kuno K, Sone M.
    Magn Reson Med Sci; 2016 Oct 11; 15(4):379-385. PubMed ID: 27001396
    [Abstract] [Full Text] [Related]

  • 2. Volume Quantification of Endolymph after Intravenous Administration of a Single Dose of Gadolinium Contrast Agent: Comparison of 18- versus 8-minute Imaging Protocols.
    Naganawa S, Ohashi T, Kanou M, Kuno K, Sone M, Ikeda M.
    Magn Reson Med Sci; 2015 Oct 11; 14(4):257-62. PubMed ID: 25833267
    [Abstract] [Full Text] [Related]

  • 3. Relationship between Contrast Enhancement of the Perivascular Space in the Basal Ganglia and Endolymphatic Volume Ratio.
    Ohashi T, Naganawa S, Katagiri T, Kuno K.
    Magn Reson Med Sci; 2018 Jan 10; 17(1):67-72. PubMed ID: 28592709
    [Abstract] [Full Text] [Related]

  • 4. Time course for measuring endolymphatic size in healthy volunteers following intravenous administration of gadoteridol.
    Naganawa S, Suzuki K, Yamazaki M, Sakurai Y, Ikeda M.
    Magn Reson Med Sci; 2014 Jan 10; 13(2):73-80. PubMed ID: 24769637
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of endolymphatic hydrops using 3-T MRI after intravenous gadolinium injection.
    Imai T, Uno A, Kitahara T, Okumura T, Horii A, Ohta Y, Sato T, Okazaki S, Kamakura T, Ozono Y, Watanabe Y, Hanada Y, Imai R, Ohata K, Inohara H.
    Eur Arch Otorhinolaryngol; 2017 Dec 10; 274(12):4103-4111. PubMed ID: 28948373
    [Abstract] [Full Text] [Related]

  • 6. Semi-quantification of endolymphatic size on MR imaging after intravenous injection of single-dose gadodiamide: comparison between two types of processing strategies.
    Naganawa S, Suzuki K, Nakamichi R, Bokura K, Yoshida T, Sone M, Homann G, Nakashima T, Ikeda M.
    Magn Reson Med Sci; 2013 Dec 25; 12(4):261-9. PubMed ID: 24172793
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance imaging of endolymphatic hydrops: a comparison of methods with and without gadolinium-based contrast agent administration.
    Ohashi T, Naganawa S, Nasu Y, Kuno K, Kato K.
    Nagoya J Med Sci; 2023 May 25; 85(2):299-309. PubMed ID: 37346829
    [Abstract] [Full Text] [Related]

  • 8. Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR.
    Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T.
    Magn Reson Med Sci; 2010 May 25; 9(4):237-42. PubMed ID: 21187694
    [Abstract] [Full Text] [Related]

  • 9. Quantification of Endolymphatic Space Volume after Intravenous Administration of a Single Dose of Gadolinium-based Contrast Agent: 3D-real Inversion Recovery versus HYDROPS-Mi2.
    Ohashi T, Naganawa S, Takeuchi A, Katagiri T, Kuno K.
    Magn Reson Med Sci; 2020 May 01; 19(2):119-124. PubMed ID: 31061269
    [Abstract] [Full Text] [Related]

  • 10. Magnetic Resonance Imaging of Ménière's Disease After Intravenous Administration of Gadolinium.
    Shi S, Guo P, Wang W.
    Ann Otol Rhinol Laryngol; 2018 Nov 01; 127(11):777-782. PubMed ID: 30156867
    [Abstract] [Full Text] [Related]

  • 11. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière's disease.
    Nakashima T, Naganawa S, Teranishi M, Tagaya M, Nakata S, Sone M, Otake H, Kato K, Iwata T, Nishio N.
    Acta Otolaryngol; 2010 Mar 01; 130(3):338-43. PubMed ID: 19685358
    [Abstract] [Full Text] [Related]

  • 12. [Visualization of endolymphatic hydrops in 3D-FLAIR MRI after intratympanic Gd-DTPA administration in Meniere's disease patients].
    Zhang DG, Shi HL, Fan ZM, Wang GB, Han YC, Li YW, Wang HB.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Aug 01; 48(8):628-33. PubMed ID: 24195817
    [Abstract] [Full Text] [Related]

  • 13. The Correlation Between Endolymphatic Hydrops and blood-labyrinth barrier Permeability of Meniere Disease.
    Zhang W, Xie J, Hui L, Li S, Zhang B.
    Ann Otol Rhinol Laryngol; 2021 Jun 01; 130(6):578-584. PubMed ID: 33047609
    [Abstract] [Full Text] [Related]

  • 14. Magnetic resonance imaging with intravenous gadoteridol injection based on 3D-real IR sequence of the inner ear in Meniere's disease patient: feasibility in 3.5-h time interval.
    Chen W, Geng Y, Lin N, Yu S, Sha Y.
    Acta Otolaryngol; 2021 Oct 01; 141(10):899-906. PubMed ID: 34520311
    [Abstract] [Full Text] [Related]

  • 15. The Correlation Between Endolymphatic Hydrops and Clinical Features of Meniere Disease.
    Zhang W, Hui L, Zhang B, Ren L, Zhu J, Wang F, Li S.
    Laryngoscope; 2021 Jan 01; 131(1):E144-E150. PubMed ID: 32083730
    [Abstract] [Full Text] [Related]

  • 16. 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness.
    Tagaya M, Teranishi M, Naganawa S, Iwata T, Yoshida T, Otake H, Nakata S, Sone M, Nakashima T.
    Acta Otolaryngol; 2010 Jun 01; 130(6):665-9. PubMed ID: 19958242
    [Abstract] [Full Text] [Related]

  • 17. Assessment of endolymphatic hydrops and otolith function in patients with Ménière's disease.
    Okumura T, Imai T, Takimoto Y, Takeda N, Kitahara T, Uno A, Kamakura T, Osaki Y, Watanabe Y, Inohara H.
    Eur Arch Otorhinolaryngol; 2017 Mar 01; 274(3):1413-1421. PubMed ID: 27942898
    [Abstract] [Full Text] [Related]

  • 18. Visualization of endolymphatic hydrops after administration of a standard dose of an intravenous gadolinium-based contrast agent.
    Tanigawa T, Tamaki T, Yamamuro O, Tanaka H, Nonoyama H, Shiga A, Sato T, Ueda H.
    Acta Otolaryngol; 2011 Jun 01; 131(6):596-601. PubMed ID: 21351819
    [Abstract] [Full Text] [Related]

  • 19. Imaging of endolymphatic hydrops in 10 minutes: a new strategy to reduce scan time to one third.
    Naganawa S, Kawai H, Ikeda M, Sone M, Nakashima T.
    Magn Reson Med Sci; 2015 Jun 01; 14(1):77-83. PubMed ID: 25500782
    [Abstract] [Full Text] [Related]

  • 20. Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylene-triamine pentaacetic acid.
    Naganawa S, Sugiura M, Kawamura M, Fukatsu H, Sone M, Nakashima T.
    AJNR Am J Neuroradiol; 2008 Apr 01; 29(4):724-6. PubMed ID: 18184846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.